EP1349548A4 - Methodes et compositions de traitement d'une parodontopathie - Google Patents

Methodes et compositions de traitement d'une parodontopathie

Info

Publication number
EP1349548A4
EP1349548A4 EP01994350A EP01994350A EP1349548A4 EP 1349548 A4 EP1349548 A4 EP 1349548A4 EP 01994350 A EP01994350 A EP 01994350A EP 01994350 A EP01994350 A EP 01994350A EP 1349548 A4 EP1349548 A4 EP 1349548A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
periodontal disease
treating periodontal
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP01994350A
Other languages
German (de)
English (en)
Other versions
EP1349548A2 (fr
Inventor
George D Hartman
Sevgi B Rodan
Gideon A Rodan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1349548A2 publication Critical patent/EP1349548A2/fr
Publication of EP1349548A4 publication Critical patent/EP1349548A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP01994350A 2001-01-03 2001-12-28 Methodes et compositions de traitement d'une parodontopathie Ceased EP1349548A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25944101P 2001-01-03 2001-01-03
US259441P 2001-01-03
PCT/US2001/049638 WO2002053099A2 (fr) 2001-01-03 2001-12-28 Methodes et compositions de traitement d'une parodontopathie

Publications (2)

Publication Number Publication Date
EP1349548A2 EP1349548A2 (fr) 2003-10-08
EP1349548A4 true EP1349548A4 (fr) 2004-06-02

Family

ID=22984959

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01994350A Ceased EP1349548A4 (fr) 2001-01-03 2001-12-28 Methodes et compositions de traitement d'une parodontopathie

Country Status (5)

Country Link
EP (1) EP1349548A4 (fr)
JP (1) JP2004517853A (fr)
AU (1) AU2002246757B2 (fr)
CA (1) CA2432504A1 (fr)
WO (1) WO2002053099A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305668D0 (en) 2013-03-28 2013-05-15 Glaxosmithkline Ip Dev Ltd Avs6 Integrin Antagonists
SI3929196T1 (sl) 2013-09-24 2023-11-30 Fujifilm Corporation Farmacevtska sestava spojine, ki vsebuje dušik ali njegovo sol ali njegov kovinski kompleks
GB201417002D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compound
GB201417011D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417094D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417018D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201604680D0 (en) 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031099A1 (fr) * 1997-12-17 1999-06-24 Merck & Co., Inc. Antagonistes du recepteur de l'integrine
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
WO2000006169A1 (fr) * 1998-07-29 2000-02-10 Merck & Co., Inc. Antagonistes des recepteurs de l'integrine
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists
WO2000072801A2 (fr) * 1999-06-02 2000-12-07 Merck & Co., Inc. Antagonistes du recepteur de l'alpha v integrine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999031099A1 (fr) * 1997-12-17 1999-06-24 Merck & Co., Inc. Antagonistes du recepteur de l'integrine
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists
WO2000006169A1 (fr) * 1998-07-29 2000-02-10 Merck & Co., Inc. Antagonistes des recepteurs de l'integrine
WO2000072801A2 (fr) * 1999-06-02 2000-12-07 Merck & Co., Inc. Antagonistes du recepteur de l'alpha v integrine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO02053099A3 *

Also Published As

Publication number Publication date
WO2002053099A3 (fr) 2002-09-12
EP1349548A2 (fr) 2003-10-08
JP2004517853A (ja) 2004-06-17
CA2432504A1 (fr) 2002-07-11
AU2002246757B2 (en) 2006-02-02
WO2002053099A2 (fr) 2002-07-11

Similar Documents

Publication Publication Date Title
IL160933A0 (en) Methods and compositions for treating ?cap associated diseases
HK1089364A1 (en) Topical compositions and methods for treating pain
EP1446114A4 (fr) Compositions et methodes de traitement de l'osteoporose
AU2002357119A8 (en) Mitocidal compositions and methods
EP1416961A4 (fr) Composition et procede pour le traitement d'une maladie
GB0110288D0 (en) Composition and treatment method
EP1438062A4 (fr) Methodes et compositions pour le traitement de lesions cutanees
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
EP1572118A4 (fr) Methodes et compositions de traitement de cancer au moyen des genes 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883
HUP0400609A3 (en) Wet-skin treatment compositions
EP1461047A4 (fr) Compositions et techniques de traitement d'animaux
GB0012061D0 (en) Hair treatment compositions
AU2002357748A8 (en) Osteopontin-related compositions and methods
GB0126643D0 (en) Composition and process
EP1349548A4 (fr) Methodes et compositions de traitement d'une parodontopathie
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
AU2003275433A8 (en) Compositions and methods for treating pain
EP1261331A4 (fr) Procede et compositions permettant de traiter les maladies fibrosantes
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
AU2002353915A1 (en) Methods and compositions for treating rotavirus-mediated disease
AU2002359869A8 (en) Pak5-related compositions and methods
GB0000556D0 (en) Malodour treatment compositions
GB0012064D0 (en) Hair treatment compositions
EP1397507A4 (fr) Procedes destines a traiter des maladies cardio-vasculaires au moyen des genes 10218
IL159333A0 (en) Plant treatment composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030804

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040421

17Q First examination report despatched

Effective date: 20040824

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20060101